Cargando…
Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
Autores principales: | Ma, Dongjie, Li, Shanqing, Cui, Yushang, Li, Li, Liu, Hongsheng, Chen, Yeye, Zhou, Xiaoyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859468/ https://www.ncbi.nlm.nih.gov/pubmed/33613708 http://dx.doi.org/10.3892/ol.2021.12480 |
Ejemplares similares
-
Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
por: Ma, Dongjie, et al.
Publicado: (2018) -
Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: Tian, Feng, et al.
Publicado: (2023) -
circDENND4C Promotes Proliferation and Metastasis of Lung Cancer by Upregulating BRD4 Signaling Pathway
por: Ma, Dongjie, et al.
Publicado: (2021) -
Retracted: TILRR Aggravates Sepsis-Induced Acute Lung Injury by Suppressing the PI3K/Akt Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway
por: Healthcare Engineering, Journal of
Publicado: (2023)